Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05KED
|
||||
| Former ID |
DIB006230
|
||||
| Drug Name |
Rocilinostat
|
||||
| Indication | Multiple myeloma [ICD9: 203; ICD10:C90] | Phase 2 | [1] | ||
| Company |
Acetylon pharmaceuticals
|
||||
| Structure |
|
Download2D MOL |
|||
| Target and Pathway | |||||
| Target(s) | Histone deacetylase | Target Info | Inhibitor | [2] | |
| References | |||||
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800032606) | ||||
| REF 2 | National Cancer Institute Drug Dictionary (drug id 698408). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.